The 29-year-old daughter of Tim McGraw and Faith Hill revealed she now considers the popular weight-loss drug "probably one of the worst things" she ever did for herself, a cautionary note as millions of Americans chase the same shortcut.
Gracie McGraw took to Instagram Stories on Monday to lay out, in blunt terms, what three years on Ozempic cost her. She started the drug in 2022 after being diagnosed with polyendocrine metabolic ovarian syndrome, a hormonal condition, previously called PCOS, that can cause irregular periods, weight gain, and long-term risks like type 2 diabetes. The drug did what it was supposed to do. It helped manage her symptoms. It made her lose weight. And it fed a disorder she thought she had left behind.
As Page Six reported, McGraw told her followers:
"Yes, it f, king worked and made my PCOS symptoms easier to control, but it also brought back my ED and negative views on my body."
She added that she eventually recognized what was happening, that the drug had become a vehicle for something darker than medical treatment.
"I realized, 'Holy crap, I have been feeding into my eating disorder this whole time under the guise of this miracle shot.'"
McGraw, a New York University graduate, did not name her profession directly but made clear that getting thin changed how the world treated her. She said she received more professional opportunities after losing weight than at any other point in her life.
That kind of incentive is hard to walk away from. And for someone who grew up in the public eye as the eldest daughter of two of country music's biggest names, the pressure ran deeper than a paycheck.
McGraw said she had been "called fat and ugly" her entire life, by magazines, by strangers on the internet. Critics compared her unfavorably to her sisters Maggie, 27, and Audrey, 24, telling her she had "different genes" because she was "the 'fat' one and didn't have the looks" of her family.
So when Ozempic delivered results, she embraced them. She described her initial reaction in straightforward terms:
"At that time, I thought it was the best decision I ever made because I finally lost weight and got skinny."
Only later did the cost become clear.
McGraw first went public about her Ozempic use in 2023, when she defended the decision as medically necessary. At the time, she described an appointment with her endocrinologist in which they discussed her hormonal condition and decided to try medication to "regulate my body more normally." She switched from Ozempic to a low dose of Mounjaro, another GLP-1 drug, a class of diabetes medications now widely used for weight loss.
Her tone on Monday was different. Looking back now, McGraw called Ozempic "probably one of the worst things I've ever done for myself." She is off the drug entirely and gaining weight back.
She told followers she is "doing so good" but acknowledged "slip-ups from time to time" when it comes to how she sees her own body. That kind of honesty is uncommon in the celebrity world, where Ozempic and its cousins have become an open secret, widely used, rarely discussed with any candor about the downsides.
McGraw also pushed back against the idea that people should stay quiet about the risks. She urged empathy but rejected silence:
"But, telling people to not speak on this is incredibly wrong and damaging. It's promoting created thinness as a goal not as danger. We are at a time when we need to be taking care of ourselves and our people."
Ozempic was developed and approved as a Type 2 diabetes treatment. Its rapid adoption as a weight-loss tool has made it one of the most talked-about drugs in America, and one of the least scrutinized in terms of its psychological effects on people with histories of disordered eating. The Mayo Clinic notes that weight loss is recommended as an early treatment for PCOS to lower long-term health risks, but the line between medical weight management and compulsive thinness is one that millions of patients navigate without much guidance.
McGraw's account puts a specific face on a pattern that eating disorder specialists have warned about for months. A drug that suppresses appetite and delivers rapid visible results can, for someone with a history of disordered eating, become indistinguishable from the disorder itself. McGraw said as much: the "miracle shot" became the mechanism through which her eating disorder operated, undetected, for years.
Tim McGraw and Faith Hill, who married in 1996, have not publicly commented on their daughter's posts. Gracie McGraw did not name her endocrinologist or specify whether she remains on Mounjaro at a lower dose or has discontinued GLP-1 drugs altogether. Some details remain unclear, including whether her reference to "three years" on Ozempic accounts for the period after she reportedly switched to Mounjaro in 2023.
What is clear is that she is no longer willing to treat the drug as a success story. And she does not want anyone else pressured into silence about what it can do.
When a culture celebrates a drug for making people thin and punishes anyone who asks what it costs, the people paying the price deserve to be heard, not hushed.
